Bluesky Facebook Reddit Email

Estimated vaccine effectiveness against symptomatic SARS-CoV-2 infection

12.22.21 | JAMA Network

Sony Alpha a7 IV (Body Only)

Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.

What The Study Did: This analysis of 1.2 million symptomatic adults who were tested for COVID-19 at a pharmacy between May and August of this year found that unvaccinated individuals were more likely to be infected with SARSCoV-2 than vaccinated adults.

Authors: Sreekanth K. Chaguturu, M.D., of CVS Health in Woonsocket, Rhode Island, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2021.43346)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.43346?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=122221

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

JAMA Network Open

Keywords

Article Information

Contact Information

JAMA Network Media Relations
JAMA Network
mediarelations@jamanetwork.org

How to Cite This Article

APA:
JAMA Network. (2021, December 22). Estimated vaccine effectiveness against symptomatic SARS-CoV-2 infection. Brightsurf News. https://www.brightsurf.com/news/L599QD78/estimated-vaccine-effectiveness-against-symptomatic-sars-cov-2-infection.html
MLA:
"Estimated vaccine effectiveness against symptomatic SARS-CoV-2 infection." Brightsurf News, Dec. 22 2021, https://www.brightsurf.com/news/L599QD78/estimated-vaccine-effectiveness-against-symptomatic-sars-cov-2-infection.html.